logo
logo
Sign in

Multiple Sclerosis Therapies Market Report With Industry Trends and Regional Growth by 2025

avatar
Nasir Jones

According to IMARC Group’s latest report, titled “Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global multiple sclerosis therapies market experienced moderate growth during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth by 2025.

Multiple sclerosis (MS) is a severe inflammatory immune-mediated condition that may cause axonal transection, demyelination and neurodegeneration of the nerve cells in the brain and spinal cord. Some of the commonly used therapies to treat MS include oral and infused medicines, administration of injectables, antidepressants, muscle relaxants and physical therapy. Multiple sclerosis therapies help in managing the symptoms to reduce the frequency of the relapses and control the heart rate and blood pressure of the patient.

The growing prevalence of primary-progressive multiple sclerosis, secondary-progressive multiple sclerosis, and progressive-relapsing multiple sclerosis across the globe is primarily driving the demand for MS therapies. Furthermore, the increasing geriatric population, who are more prone to multiple sclerosis, is also providing a thrust to the market. Besides this, the healthcare providers are widely utilizing immunosuppressants that control autoimmune attacks and lower relapses among patients suffering from multiple sclerosis. Additionally, numerous technological advancements, such as the development of innovative monoclonal bodies, immunosuppressants, immunomodulators, and interferons for the effective treatment of multiple sclerosis, are further augmenting the market growth. Moreover, governments of several countries are launching campaigns to spread awareness regarding the available treatment alternatives among the masses, which is expected to further propel the market in the coming years.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Get a PDF sample for more detailed market insightshttps://www.imarcgroup.com/multiple-sclerosis-therapies-market/requestsample

Multiple Sclerosis Therapies Market Competitive Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the multiple sclerosis therapies market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Merck & Co. Inc.
  • Bayer Aktiengesellschaft
  • Sanofi S.A. and Teva Pharmaceutical Industries Ltd.
  • Bristol-Myers Squibb Company
  • Hoffmann-La Roche AG (Roche Holding AG)
  • GlaxoSmithKline Plc
  • Biogen Inc.
  • Abbvie Inc.
  • Novartis AG

The report has segmented the global multiple sclerosis therapies market on the basis of drug, drug type, route of administration, distribution channel and region.

Breakup by Drug:

  • Immunomodulators
    • Copaxone
    • Avonex/Plegridy
    • Gilneya
    • Tysabri
    • Betaseron/Extavia
    • Tecifidera
    • Rebif
    • Ampyra
  • Immunosuppressants
    • Aubagio
    • Lemtrada
    • Ocrelizumab
    • Zinbryta

Breakup by Drug Type:

  • Biologic Drugs
  • Small Molecule Drugs

Breakup by Route of Administration:

  • Oral
  • Injectable
  • Intravenous

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Explore full report with table of contentshttps://www.imarcgroup.com/multiple-sclerosis-therapies-market

Key highlights of the report:

  • Market Performance (2014-2019)
  • Market Outlook (2020-2025)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Related Reports:

Cardiac Resynchronization Therapy (CRT) Markethttps://www.imarcgroup.com/cardiac-resynchronization-therapy-market

Osteoarthritis Therapeutics Market Reporthttps://www.imarcgroup.com/osteoarthritis-therapeutics-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US             
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
USA: +1-631-791-1145 | Europe & Africa: +44-753-713

collect
0
avatar
Nasir Jones
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more